Tofacitinib, an Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: Year 2 Efficacy and Safety Results From a 24-Month Phase 3 Study

Author(s):
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.M.; Keystone, E.; Kremer, J.M.; Zerbini, C.; Cardiel, M.H.; Cohen, S.B.; Nash, P.T.; Song, Y.; Tegzova, D.; Wyman, B.; Gruben, D.; Benda, B.; Wallenstein, G.; Krishnaswami, S.; Zwillich, S.H.; Bradley, J.; Connell, C.A.; ORAL Scan Investigators
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-10-31
Language
English
Is part of
Arthritis and Rheumatism (2012), Vol. 64, no. 10, p. S546-S547
hdl
1887/106466